These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23231513)

  • 1. Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Józwiak S; Stein K; Kotulska K
    Future Oncol; 2012 Dec; 8(12):1515-23. PubMed ID: 23231513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice.
    Cockerell I; Christensen J; Hoei-Hansen CE; Holst L; Grenaa Frederiksen M; Issa-Epe AI; Nedregaard B; Solhoff R; Heimdal K; Johannessen Landmark C; Lund C; Nærland T
    Orphanet J Rare Dis; 2023 Dec; 18(1):377. PubMed ID: 38042867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of everolimus on small renal angiomyolipoma in cases of tuberous sclerosis complex-related epilepsy and subependymal giant cell astrocytoma.
    Hatano T; Yuri Y
    Asian J Surg; 2023 Mar; 46(3):1236-1237. PubMed ID: 36031512
    [No Abstract]   [Full Text] [Related]  

  • 4. Subependymal giant-cell astrocytoma: A surgical review in the modern era of mTOR inhibitors.
    Danassegarane G; Tinois J; Sahler Y; Aouaissia S; Riffaud L
    Neurochirurgie; 2022 Dec; 68(6):627-636. PubMed ID: 35907444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?
    Schachenhofer J; Gruber VE; Fehrer SV; Haider C; Glatter S; Liszewska E; Höftberger R; Aronica E; Rössler K; Jaworski J; Scholl T; Feucht M
    Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12974. PubMed ID: 38562027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Events of Everolimus in Patients with Tuberous Sclerosis Complex Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma.
    Gau SY; Chen SL; Chang CS; Tsao TF; Tsai JD
    Int J Med Sci; 2023; 20(10):1358-1362. PubMed ID: 37786437
    [No Abstract]   [Full Text] [Related]  

  • 7. An updated meta-analysis of effectiveness and safety of mTOR inhibitors in the management of tuberous sclerosis complex patients.
    Liu M; Ye J; You X
    Childs Nerv Syst; 2024 Mar; 40(3):823-829. PubMed ID: 37906297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors.
    Boop S; Bonda D; Randle S; Leary S; Vitanza N; Crotty E; Novotny E; Friedman S; Ellenbogen RG; Durfy S; Goldstein H; Ojemann JG; Hauptman JS
    Pediatr Neurosurg; 2023; 58(3):150-159. PubMed ID: 37232001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Therapy with Everolimus for Subependymal Giant Cell Astrocytoma: A Case Report.
    Karita H; Tsuda K; Kono M; Yamamoto T; Ihara S
    NMC Case Rep J; 2023; 10():291-297. PubMed ID: 37953906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case of subependymal giant cell astrocytoma presenting with spontaneous intratumoral hemorrhage.
    Gotecha S; Punia P; Shobhit C; Chugh A; Kotecha M
    J Cancer Res Ther; 2023 Dec; ():. PubMed ID: 38102901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Sirolimus in Patients with Tuberous Sclerosis Complex under Two Years of Age-A Bicenter Retrospective Study.
    Śmiałek D; Jóźwiak S; Kotulska K
    J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TTF-1: A Well-Favored Addition to the Immunohistochemistry Armamentarium as a Diagnostic Marker of SEGA.
    Dutta R; Sharma MC; Suri V; Sarkar C; Garg A; Suri A; Kale SS
    World Neurosurg; 2022 Mar; 159():e62-e69. PubMed ID: 34871801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus-induced aphthous stomatitis controlled by apremilast in a heart-transplant patient.
    Mahé E
    Ann Dermatol Venereol; 2023 Jun; 150(2):158-159. PubMed ID: 36739218
    [No Abstract]   [Full Text] [Related]  

  • 14. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
    Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Frost M; Belousova E; Sauter M; Nonomura N; Brakemeier S; de Vries PJ; Whittemore VH; Chen D; Sahmoud T; Shah G; Lincy J; Lebwohl D; Budde K
    Lancet; 2013 Mar; 381(9869):817-24. PubMed ID: 23312829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.
    Kingswood JC; Jozwiak S; Belousova ED; Frost MD; Kuperman RA; Bebin EM; Korf BR; Flamini JR; Kohrman MH; Sparagana SP; Wu JY; Brechenmacher T; Stein K; Berkowitz N; Bissler JJ; Franz DN
    Nephrol Dial Transplant; 2014 Jun; 29(6):1203-10. PubMed ID: 24729041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex.
    Cappellano AM; Senerchia AA; Adolfo F; Paiva PM; Pinho R; Covic A; Cavalheiro S; Saba N
    Childs Nerv Syst; 2013 Dec; 29(12):2301-5. PubMed ID: 23743818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma.
    Krueger DA; Care MM; Agricola K; Tudor C; Mays M; Franz DN
    Neurology; 2013 Feb; 80(6):574-80. PubMed ID: 23325902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults.
    Weiser A; Sanchez Bergman A; Machaalani C; Bennett J; Roth P; Reimann RR; Nazarian J; Guerreiro Stucklin AS
    Front Oncol; 2023; 13():1254645. PubMed ID: 37781183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin and rapalogs for tuberous sclerosis complex.
    Sasongko TH; Kademane K; Chai Soon Hou S; Jocelyn TXY; Zabidi-Hussin Z
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011272. PubMed ID: 37432030
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.